{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:18:07Z","timestamp":1737436687027,"version":"3.33.0"},"posted":{"date-parts":[[2024,12,31]]},"group-title":"In Review","reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,9,25]]},"abstract":"<title>Abstract<\/title>\n        <p>Triple-negative breast cancer (TNBC) is an aggressive subtype often characterized by high lymphocyte infiltration, including tumor-infiltrating B cells (TIBs). These cells are present even in early stages of TNBC and associated with microinvasion. This study shows that co-culturing TNBC cells with B cells increases Interleukin-1\u03b2 (IL-1\u03b2) expression and secretion. We further show that  B cell-induced IL-1\u03b2 activates NF\u03baB signaling, leading to higher expression of target genes and promoting IL-1\u03b2-dependent increases in matrix metalloproteinase (MMP) activity, invasion, and migration. Immunohistochemical analysis of IL-1\u03b2 and TIBs in triple-negative ductal carcinoma in situ (DCIS, n=90) and invasive TNBC (n=171) revealed that in DCIS, TIBs correlated with IL-1\u03b2 expression and microinvasion, with IL-1\u03b2 also linked to recurrence. In invasive TNBC, IL-1\u03b2 expression correlated with TIB density and stage, with high IL-1\u03b2 levels associated with poorer survival outcomes. These findings suggest that early B cell presence in TNBC can induce IL-1\u03b2 secretion, enhancing invasion and mobility through IL-1\u03b2-NF\u03baB signaling. This highlights the potential of IL-1 inhibitors as preventive and therapeutic options for hormone receptor-negative DCIS and TNBC.<\/p>","DOI":"10.21203\/rs.3.rs-5153341\/v1","type":"posted-content","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T05:28:12Z","timestamp":1735622892000},"source":"Crossref","is-referenced-by-count":0,"title":["B cells enhance IL-1 beta\u00a0 driven invasiveness in triple-negative breast cancer"],"prefix":"10.21203","author":[{"given":"Nicole J","family":"Toney","sequence":"first","affiliation":[{"name":"Helen F Graham Cancer Center, and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn M.","family":"Opdenaker","sequence":"additional","affiliation":[{"name":"Helen F Graham Cancer Center, and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Frerichs","sequence":"additional","affiliation":[{"name":"Helen F Graham Cancer Center, and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin R.","family":"Modarai","sequence":"additional","affiliation":[{"name":"Helen F Graham Cancer Center, and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihui","family":"Ma","sequence":"additional","affiliation":[{"name":"Helen F Graham Cancer Center, and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Archinal","sequence":"additional","affiliation":[{"name":"Helen F Graham Cancer Center, and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace O","family":"Ajayi","sequence":"additional","affiliation":[{"name":"Helen F Graham Cancer Center, and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Sims-Mourtada","sequence":"additional","affiliation":[{"name":"Helen F Graham Cancer Center, and Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/107327481001700305","article-title":"A review of triple-negative breast cancer","volume":"17","author":"Ismail-Khan R","year":"2010","unstructured":"Ismail-Khan, R. & Bui, M. M. A review of triple-negative breast cancer. Cancer Control. 17, 173\u2013176. 10.1177\/107327481001700305 (2010).","journal-title":"Cancer Control"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen TO","year":"2004","unstructured":"Nielsen, T. O. et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin. Cancer Res. 10, 5367\u20135374. 10.1158\/1078-0432.CCR-04-0220 (2004).","journal-title":"Clin. Cancer Res."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/his.14129","article-title":"The prognostic significance of ALDH1A1 expression in early invasive breast cancer","volume":"77","author":"Althobiti M","year":"2020","unstructured":"Althobiti, M. et al. The prognostic significance of ALDH1A1 expression in early invasive breast cancer. Histopathology. 77, 437\u2013448. 10.1111\/his.14129 (2020).","journal-title":"Histopathology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7150\/jca.10944","article-title":"Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer","volume":"7","author":"Qiu J","year":"2016","unstructured":"Qiu, J. et al. Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer. J. Cancer. 7, 167\u2013173. 10.7150\/jca.10944 (2016).","journal-title":"J. Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/ol.2020.11948","article-title":"Impact of molecular subtypes on metastatic behavior and overall survival in patients with metastatic breast cancer: A single-center study combined with a large cohort study based on the Surveillance, Epidemiology and End Results database","volume":"20","author":"Yang H","year":"2020","unstructured":"Yang, H. et al. Impact of molecular subtypes on metastatic behavior and overall survival in patients with metastatic breast cancer: A single-center study combined with a large cohort study based on the Surveillance, Epidemiology and End Results database. Oncol. Lett. 20, 87. 10.3892\/ol.2020.11948 (2020).","journal-title":"Oncol. Lett."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jamaoncol.2016.1061","article-title":"Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review","volume":"2","author":"Stanton SE","year":"2016","unstructured":"Stanton, S. E., Adams, S. & Disis, M. L. Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review. JAMA Oncol. 2, 1354\u20131360. 10.1001\/jamaoncol.2016.1061 (2016).","journal-title":"JAMA Oncol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12935-021-02004-9","article-title":"Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis","volume":"21","author":"Qin Y","year":"2021","unstructured":"Qin, Y. et al. Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis. Cancer Cell Int. 21, 310. 10.1186\/s12935-021-02004-9 (2021).","journal-title":"Cancer Cell Int."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/his.13217","article-title":"Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ","volume":"71","author":"Miligy I","year":"2017","unstructured":"Miligy, I. et al. Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ. Histopathology. 71, 258\u2013268. 10.1111\/his.13217 (2017).","journal-title":"Histopathology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/jcp.2005.031252","article-title":"Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations","volume":"59","author":"Hussein MR","year":"2006","unstructured":"Hussein, M. R. & Hassan, H. I. Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations. J. Clin. Pathol. 59, 972\u2013977. 10.1136\/jcp.2005.031252 (2006).","journal-title":"J. Clin. Pathol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13000-015-0316-y","article-title":"Lsmall u, C. i. U. M. Immune microenvironment as a factor of breast cancer progression","volume":"10","author":"Romaniuk A","year":"2015","unstructured":"Romaniuk, A. Lsmall u, C. i. U. M. Immune microenvironment as a factor of breast cancer progression. Diagn. Pathol. 10, 79. 10.1186\/s13000-015-0316-y (2015).","journal-title":"Diagn. Pathol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/modpathol.2015.158","article-title":"The immune microenvironment of breast ductal carcinoma in situ","volume":"29","author":"Thompson E","year":"2016","unstructured":"Thompson, E. et al. The immune microenvironment of breast ductal carcinoma in situ. Mod. Pathol. 29, 249\u2013258. 10.1038\/modpathol.2015.158 (2016).","journal-title":"Mod. Pathol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10549-016-4036-0","article-title":"Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast","volume":"161","author":"Campbell MJ","year":"2017","unstructured":"Campbell, M. J. et al. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast. Breast Cancer Res. Treat. 161, 17\u201328. 10.1007\/s10549-016-4036-0 (2017).","journal-title":"Breast Cancer Res. Treat."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/ajcp\/aqw097","article-title":"An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes","volume":"146","author":"Kim A","year":"2016","unstructured":"Kim, A., Heo, S. H., Kim, Y. A., Gong, G. & Jin Lee, H. An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes. Am. J. Clin. Pathol. 146, 137\u2013144. 10.1093\/ajcp\/aqw097 (2016).","journal-title":"Am. J. Clin. Pathol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1158\/1078-0432.CCR-17-0743","article-title":"Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features","volume":"23","author":"Hendry S","year":"2017","unstructured":"Hendry, S. et al. Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features. Clin. Cancer Res. 23, 5210\u20135217. 10.1158\/1078-0432.CCR-17-0743 (2017).","journal-title":"Clin. Cancer Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/his.12437","article-title":"A significant percentage of CD20-positive TILs correlates with poor prognosis in patients with primary cutaneous malignant melanoma","volume":"65","author":"Martinez-Rodriguez M","year":"2014","unstructured":"Martinez-Rodriguez, M., Thompson, A. K. & Monteagudo, C. A significant percentage of CD20-positive TILs correlates with poor prognosis in patients with primary cutaneous malignant melanoma. Histopathology. 65, 726\u2013728. 10.1111\/his.12437 (2014).","journal-title":"Histopathology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e1075112","DOI":"10.1080\/2162402X.2015.1075112","article-title":"PD-L1 mediated the differentiation of tumor-infiltrating CD19(+) B lymphocytes and T cells in Invasive breast cancer","volume":"5","author":"Guan H","year":"2016","unstructured":"Guan, H. et al. PD-L1 mediated the differentiation of tumor-infiltrating CD19(+) B lymphocytes and T cells in Invasive breast cancer. Oncoimmunology. 5, e1075112. 10.1080\/2162402X.2015.1075112 (2016).","journal-title":"Oncoimmunology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41591-018-0309-y","article-title":"Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG","volume":"25","author":"Gu Y","year":"2019","unstructured":"Gu, Y. et al. Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG. Nat. Med. 25, 312\u2013322. 10.1038\/s41591-018-0309-y (2019).","journal-title":"Nat. Med."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s13402-019-00433-3","article-title":"The significance of cytokine-producing B cells in breast tumor-draining lymph nodes","volume":"42","author":"Mehdipour F","year":"2019","unstructured":"Mehdipour, F. et al. The significance of cytokine-producing B cells in breast tumor-draining lymph nodes. Cell. Oncol. (Dordr). 42, 381\u2013395. 10.1007\/s13402-019-00433-3 (2019).","journal-title":"Cell. Oncol. (Dordr)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s12282-021-01227-y","article-title":"Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer","volume":"28","author":"Kuroda H","year":"2021","unstructured":"Kuroda, H. et al. Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer. Breast Cancer. 28, 904\u2013914. 10.1007\/s12282-021-01227-y (2021).","journal-title":"Breast Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1158\/0008-5472.CAN-20-3773","article-title":"Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer","volume":"81","author":"Harris RJ","year":"2021","unstructured":"Harris, R. J. et al. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer Res. 81, 4290\u20134304. 10.1158\/0008-5472.CAN-20-3773 (2021).","journal-title":"Cancer Res."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41523-021-00291-z","article-title":"Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome","volume":"7","author":"Wortman JC","year":"2021","unstructured":"Wortman, J. C. et al. Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome. NPJ Breast Cancer. 7, 84. 10.1038\/s41523-021-00291-z (2021).","journal-title":"NPJ Breast Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccr.2005.04.014","article-title":"De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent","volume":"7","author":"Visser KE","year":"2005","unstructured":"de Visser, K. E., Korets, L. V. & Coussens, L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell. 7, 411\u2013423. 10.1016\/j.ccr.2005.04.014 (2005).","journal-title":"Cancer Cell."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature08782","article-title":"B-cell-derived lymphotoxin promotes castration-resistant prostate cancer","volume":"464","author":"Ammirante M","year":"2010","unstructured":"Ammirante, M., Luo, J. L., Grivennikov, S., Nedospasov, S. & Karin, M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature. 464, 302\u2013305. 10.1038\/nature08782 (2010).","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.humpath.2016.03.022","article-title":"Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome","volume":"54","author":"Garg K","year":"2016","unstructured":"Garg, K. et al. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome. Hum. Pathol. 54, 157\u2013164. 10.1016\/j.humpath.2016.03.022 (2016).","journal-title":"Hum. Pathol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e38222","DOI":"10.1371\/journal.pone.0038222","article-title":"A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts","volume":"7","author":"Meyer S","year":"2012","unstructured":"Meyer, S. et al. A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One. 7, e38222. 10.1371\/journal.pone.0038222 (2012).","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e64159","DOI":"10.1371\/journal.pone.0064159","article-title":"B cells promote tumor progression via STAT3 regulated-angiogenesis","volume":"8","author":"Yang C","year":"2013","unstructured":"Yang, C. et al. B cells promote tumor progression via STAT3 regulated-angiogenesis. PLoS One. 8, e64159. 10.1371\/journal.pone.0064159 (2013).","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12967-022-03319-5","article-title":"Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers","volume":"20","author":"Toney NJ","year":"2022","unstructured":"Toney, N. J. et al. Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers. J. Transl Med. 20, 112. 10.1186\/s12967-022-03319-5 (2022).","journal-title":"J. Transl Med."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1158\/1078-0432.CCR-18-2202","article-title":"Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment","volume":"25","author":"Tulotta C","year":"2019","unstructured":"Tulotta, C. et al. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment. Clin. Cancer Res. 25, 2769\u20132782. 10.1158\/1078-0432.CCR-18-2202 (2019).","journal-title":"Clin. Cancer Res."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"R421","DOI":"10.1530\/ERC-17-0309","article-title":"The role of IL-1B in breast cancer bone metastasis","volume":"25","author":"Tulotta C","year":"2018","unstructured":"Tulotta, C. & Ottewell, P. The role of IL-1B in breast cancer bone metastasis. Endocr. Relat. Cancer. 25, R421\u2013R434. 10.1530\/ERC-17-0309 (2018).","journal-title":"Endocr. Relat. Cancer"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cbi.2016.08.021","article-title":"Elevated IL-1\u03b2 expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone","volume":"258","author":"Jeon M","year":"2016","unstructured":"Jeon, M., Han, J., Nam, S. J., Lee, J. E. & Kim, S. Elevated IL-1\u03b2 expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone. Chem. Biol. Interact. 258, 126\u2013133. 10.1016\/j.cbi.2016.08.021 (2016).","journal-title":"Chem. Biol. Interact."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3389\/fimmu.2019.00757","article-title":"Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer","volume":"10","author":"Liubomirski Y","year":"2019","unstructured":"Liubomirski, Y. et al. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer. Front. Immunol. 10, 757. 10.3389\/fimmu.2019.00757 (2019).","journal-title":"Front. Immunol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1177\/1947601911432496","article-title":"Exploring molecular pathways of triple-negative breast cancer","volume":"2","author":"Ossovskaya V","year":"2011","unstructured":"Ossovskaya, V. et al. Exploring molecular pathways of triple-negative breast cancer. Genes Cancer. 2, 870\u2013879. 10.1177\/1947601911432496 (2011).","journal-title":"Genes Cancer"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e0169622","DOI":"10.1371\/journal.pone.0169622","article-title":"NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells","volume":"12","author":"Pires BR","year":"2017","unstructured":"Pires, B. R. et al. NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells. PLoS One. 12, e0169622. 10.1371\/journal.pone.0169622 (2017).","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e106966","DOI":"10.1371\/journal.pone.0106966","article-title":"NF-kappaB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression","volume":"9","author":"Smith SM","year":"2014","unstructured":"Smith, S. M., Lyu, Y. L. & Cai, L. NF-kappaB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression. PLoS One. 9, e106966. 10.1371\/journal.pone.0106966 (2014).","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/jcb.24159","article-title":"N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell invasion through suppressing NF-KB activation and inhibiting matrix metalloproteinase-9 expression","volume":"113","author":"Kang H","year":"2012","unstructured":"Kang, H. et al. N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell invasion through suppressing NF-KB activation and inhibiting matrix metalloproteinase-9 expression. J. Cell. Biochem. 113, 2845\u20132855. 10.1002\/jcb.24159 (2012).","journal-title":"J. Cell. Biochem."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1158\/0008-5472.Can-12-3655","article-title":"DDB2: a novel regulator of NF-\u03baB and breast tumor invasion","volume":"73","author":"Ennen M","year":"2013","unstructured":"Ennen, M. et al. DDB2: a novel regulator of NF-\u03baB and breast tumor invasion. Cancer Res. 73, 5040\u20135052. 10.1158\/0008-5472.Can-12-3655 (2013).","journal-title":"Cancer Res."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13193-013-0234-y","article-title":"Role of NF-kappaB as a Prognostic Marker in Breast Cancer: A Pilot Study in Indian Patients","volume":"4","author":"Sarkar DK","year":"2013","unstructured":"Sarkar, D. K. et al. Role of NF-kappaB as a Prognostic Marker in Breast Cancer: A Pilot Study in Indian Patients. Indian J. Surg. Oncol. 4, 242\u2013247. 10.1007\/s13193-013-0234-y (2013).","journal-title":"Indian J. Surg. Oncol."},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190314","article-title":"Inflammasome signaling and regulation of interleukin-1 family cytokines","volume":"217","author":"Chan AH","year":"2020","unstructured":"Chan, A. H. & Schroder, K. Inflammasome signaling and regulation of interleukin-1 family cytokines. J. Exp. Med. 217 10.1084\/jem.20190314 (2020).","journal-title":"J. Exp. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.4049\/jimmunol.170.11.5630","article-title":"IKK beta plays an essential role in the phosphorylation of RelA\/p65 on serine 536 induced by lipopolysaccharide","volume":"170","author":"Yang F","year":"2003","unstructured":"Yang, F., Tang, E., Guan, K. & Wang, C. Y. IKK beta plays an essential role in the phosphorylation of RelA\/p65 on serine 536 induced by lipopolysaccharide. J. Immunol. 170, 5630\u20135635. 10.4049\/jimmunol.170.11.5630 (2003).","journal-title":"J. Immunol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"30517","DOI":"10.1074\/jbc.271.48.30517","article-title":"AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1","volume":"271","author":"Akeson AL","year":"1996","unstructured":"Akeson, A. L. et al. AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J. Biol. Chem. 271, 30517\u201330523. 10.1074\/jbc.271.48.30517 (1996).","journal-title":"J. Biol. Chem."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3892\/etm.2021.10072","article-title":"Interleukin-1 induces receptor activator of nuclear factor-\u03baB ligand-independent osteoclast differentiation in RAW264.7 cells","volume":"21","author":"Liao R","year":"2021","unstructured":"Liao, R. et al. Interleukin-1 induces receptor activator of nuclear factor-\u03baB ligand-independent osteoclast differentiation in RAW264.7 cells. Exp. Ther. Med. 21, 640. 10.3892\/etm.2021.10072 (2021).","journal-title":"Exp. Ther. Med."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/789414","author":"Filippi I","year":"2015","unstructured":"Filippi, I., Carraro, F. & Naldini, A. Interleukin-1beta Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1alpha and NFkappaB Transcription Factors. Mediators Inflamm 789414, doi: (2015). 10.1155\/2015\/789414 (2015)."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129641","article-title":"Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer","volume":"5","author":"Garaud S","year":"2019","unstructured":"Garaud, S. et al. Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer. JCI Insight. 5 10.1172\/jci.insight.129641 (2019).","journal-title":"JCI Insight"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"954936","DOI":"10.3389\/fimmu.2022.954936","article-title":"Role of B cells as antigen presenting cells","volume":"13","author":"Rastogi I","year":"2022","unstructured":"Rastogi, I. et al. Role of B cells as antigen presenting cells. Front. Immunol. 13, 954936. 10.3389\/fimmu.2022.954936 (2022).","journal-title":"Front. Immunol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1038\/s41467-019-12160-2","article-title":"B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma","volume":"10","author":"Griss J","year":"2019","unstructured":"Griss, J. et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat. Commun. 10, 4186. 10.1038\/s41467-019-12160-2 (2019).","journal-title":"Nat. Commun."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1073\/pnas.1812266115","article-title":"Blocking IL-1beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation","volume":"116","author":"Kaplanov I","year":"2019","unstructured":"Kaplanov, I. et al. Blocking IL-1beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc. Natl. Acad. Sci. U S A. 116, 1361\u20131369. 10.1073\/pnas.1812266115 (2019).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","article-title":"The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions","volume":"25","author":"Apte RN","year":"2006","unstructured":"Apte, R. N. et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25, 387\u2013408. 10.1007\/s10555-006-9004-4 (2006).","journal-title":"Cancer Metastasis Rev."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity","volume":"50","author":"Mantovani A","year":"2019","unstructured":"Mantovani, A., Dinarello, C. A., Molgora, M. & Garlanda, C. Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity. Immunity. 50, 778\u2013795. 10.1016\/j.immuni.2019.03.012 (2019).","journal-title":"Immunity"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41416-021-01674-6","article-title":"B cell-related gene signature and cancer immunotherapy response","volume":"126","author":"Lundberg A","year":"2022","unstructured":"Lundberg, A., Li, B. & Li, R. B cell-related gene signature and cancer immunotherapy response. Br. J. Cancer. 126, 899\u2013906. 10.1038\/s41416-021-01674-6 (2022).","journal-title":"Br. J. Cancer"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: a focus on cytokines","volume":"15","author":"Shen P","year":"2015","unstructured":"Shen, P. & Fillatreau, S. Antibody-independent functions of B cells: a focus on cytokines. Nat. Rev. Immunol. 15, 441\u2013451. 10.1038\/nri3857 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu T","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S. C. NF-\u03baB signaling in inflammation. Signal. Transduct. Target. Ther. 2, 17023. 10.1038\/sigtrans.2017.23 (2017).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"10137","DOI":"10.1073\/pnas.0403621101","article-title":"NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis","volume":"101","author":"Biswas DK","year":"2004","unstructured":"Biswas, D. K. et al. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc. Natl. Acad. Sci. U S A. 101, 10137\u201310142. 10.1073\/pnas.0403621101 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1186\/s12885-015-1652-8","article-title":"Aberrant activation of NF-kappaB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ","volume":"15","author":"Barham W","year":"2015","unstructured":"Barham, W. et al. Aberrant activation of NF-kappaB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. BMC Cancer. 15, 647. 10.1186\/s12885-015-1652-8 (2015).","journal-title":"BMC Cancer"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1179064418761639","DOI":"10.1177\/1179064418761639","article-title":"The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules","volume":"11","author":"Arnold KM","year":"2018","unstructured":"Arnold, K. M. et al. The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules. Cancer Growth Metastasis. 11, 1179064418761639. 10.1177\/1179064418761639 (2018).","journal-title":"Cancer Growth Metastasis"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5153341\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5153341\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T16:14:32Z","timestamp":1737389672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5153341\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":54,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5153341\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41598-025-86064-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,12,31]]},"subtype":"preprint"}}